Very recently, a truncation mutation in CSF3R in a patient with B-cell acute lymphoblastic leukemia was reported, and the patient was shown to have a favorable response to chemotherapy plus dasatinib [20]. The gene discussed is CSF3R; the disease is B-cell acute lymphoblastic leukemia.